Ledifos 400 mg/90 mg (Sofosbuvir/Ledipasvir) Quantity:84 Tablet/s which is intended for a

which is intended for a 30‑day supply when taken as directed

300 mg of tenofovir disoproxil fumarate

The typical adult dose is 1-2 sprays per nostril once daily

Some users experience minor urethral irritation or slight bleeding

The drug's long half-life (approximately 63 to 69 hours) allows sustained receptor activation

Ledifos 400 mg/90 mg (Sofosbuvir/Ledipasvir) Quantity:84 Tablet/s which is intended for aProduct Overview Ledifos 400 mg 90 mg is a fixeddose combination tablet that contains the directacting antiviral agents sofosbuvir 400 mg and ledipasvir 90 mg. Manufactured by Hetero Drugs Ltd, this medication is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. The product is supplied as 28 tablets per bottle and is shipped within 6 to 15 days. It is classified commercially under "Medication" and "hepatitisc"